股本结构
单位：万股
| 公告日期 | 2025-05-15 | 2025-04-29 | 2025-04-29 | 2025-03-31 | 2025-03-31 | 2025-03-31 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3116.01 | 214.05 | 5351.30 | 5351.90 | 5351.30 | 1052.81 |
| 普通股本 | 3116.01 | 214.05 | 5351.30 | 5351.90 | 5351.30 | 1052.81 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-05-14 | 2025-05-01 | 2025-04-29 | 2025-03-27 | 2025-03-26 | 2024-12-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-05-15 | 3116.01 | 未披露 | 定期报告 | 2025-05-14 |
| 2025-04-29 | 214.05 | 未披露 |
更多>>
a reverse stock split of its common stock,at a ratio of 1 post-split share for every 25 pre-split shares
|
2025-05-01 |
| 2025-04-29 | 5351.30 | 未披露 | 定期报告 | 2025-04-29 |
| 2025-03-31 | 5351.90 | 未披露 | 定期报告 | 2025-03-27 |
| 2025-03-31 | 5351.30 | 未披露 | 定期报告 | 2025-03-26 |
| 2025-03-18 | 2992.97 | 0.06 | 定期报告 | 2025-02-19 |
| 2025-01-24 | 1131.90 | 0.06 | 定期报告 | 2025-01-22 |
| 2025-03-31 | 1052.81 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Series A Preferred Stock accretion
Series A Preferred Stock dividends
Preferred Stock redemption including cash premium
|
2024-12-31 |
| 2024-11-13 | 1001.49 | 未披露 | 定期报告 | 2024-11-12 |
| 2024-10-25 | 1000.88 | 0.10 | 定期报告 | 2024-10-14 |
| 2024-11-13 | 1001.49 | 0.10 |
更多>>
From June 30, 2024 to September 30, 2024
Common Stock issued for services
Preferred Stock redemption including cash premium
|
2024-09-30 |
| 2024-08-14 | 960.67 | 未披露 | 定期报告 | 2024-08-13 |
| 2024-08-14 | 929.75 | 0.40 |
更多>>
From March 31, 2024 to June 30, 2024
Common Stock issued for services
Preferred Stock redemption including cash premium
|
2024-06-30 |
| 2024-05-15 | 700.02 | 未披露 | 定期报告 | 2024-05-13 |
| 2024-05-15 | 688.19 | 0.57 |
更多>>
From December 31, 2023 to March 31, 2024
Preferred Stock redemption including cash premium
Common Stock issued for services
|
2024-03-31 |
| 2024-04-01 | 687.58 | 未披露 | 定期报告 | 2024-03-26 |
| 2024-04-01 | 299.14 | 1.00 |
更多>>
From December 31, 2022 to December 31, 2023
Stock-based compensation expense
Shares issued for vested RSU’s
Preferred Stock redemption including cash premium
|
2023-12-31 |
| 2023-11-30 | 220.11 | 未披露 | 定期报告 | 2023-11-02 |
| 2023-11-15 | 211.96 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of Series A Preferred Stock in private placement, net of discount and transaction costs $15,000,003
Preferred Stock redemption including cash premium
|
2023-09-30 |
| 2023-08-14 | 211.36 | 未披露 | 定期报告 | 2023-08-14 |
| 2023-08-14 | 211.96 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Shares issued for vested RSU’s
|
2023-06-30 |
| 2023-05-15 | 211.36 | 未披露 | 定期报告 | 2023-05-15 |
| 2023-05-15 | 208.87 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Shares issued for vested RSU's
|
2023-03-31 |
| 2023-03-31 | 207.94 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Non-employee exercise of restricted stock units
Issuance of Common Stock for split
|
2022-12-31 |
| 2022-11-30 | 207.08 | 未披露 |
更多>>
Petros Pharmaceuticals, Inc. announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. The reverse stock split will become effective at 4:05 p.m. on Wednesday, November 30, 2022.
|
2022-12-01 |
| 2022-11-14 | 2070.80 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Non-employee exercise of restricted stock units
|
2022-09-30 |
| 2022-03-31 | 2068.47 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Conversion of Preferred Stock to Common Stock
Issuance of Common Stock
Proceeds from exercise of warrants
Stock-based compensation expense
Non-employee stock-based compensation
|
2021-12-31 |
| 2021-12-27 | 2063.47 | 未披露 |
更多>>
1.Common Stock offered 1,545,183 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering and the concurrent private placement as shown above is based on 18,448,134 shares outstanding as of December 22, 2021.
|
2021-12-27 |
| 2021-12-23 | 1844.81 | 未披露 | 定期报告 | 2021-12-22 |
| 2021-12-13 | 1798.89 | 未披露 | 定期报告 | 2021-12-10 |
| 2021-12-02 | 1763.06 | 未披露 |
更多>>
1.Common Stock offered by company 2,153,333 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering and the concurrent private placement as shown above is based on 14,297,284 shares outstanding as of November 29, 2021.
|
2021-12-02 |
| 2021-12-01 | 1429.73 | 未披露 | 定期报告 | 2021-11-29 |
| 2021-10-18 | 1315.02 | 未披露 |
更多>>
1.Common Stock offered by company 3,323,616 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 9,826,599 shares outstanding as of October 13, 2021.
|
2021-10-18 |
| 2021-08-16 | 982.66 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Issuance of Common Stock for Service
|
2021-06-30 |
| 2021-05-14 | 979.83 | 未披露 |
更多>>
From December 31, 2020 To March 31, 2021
Conversion of Preferred Stock to Common Stock
Issuance of Common Stock for services
Stock-Based Compensation Expense
|
2021-03-31 |
| 2021-03-31 | 976.83 | 未披露 | 定期报告 | 2021-03-20 |
| 2021-01-29 | 976.83 | 未披露 | 定期报告 | 2021-01-28 |
| 2021-03-31 | 970.77 | 0.05 |
更多>>
From December 31, 2019 to December 31, 2020
Net proceeds received from recapitalization for the Mergers
|
2020-12-31 |
| 2020-12-11 | 970.77 | 未披露 | 定期报告 | 2020-12-02 |
a reverse stock split of its common stock,at a ratio of 1 post-split share for every 25 pre-split shares
From December 31, 2023 to December 31, 2024
Series A Preferred Stock accretion
Series A Preferred Stock dividends
Preferred Stock redemption including cash premium
From June 30, 2024 to September 30, 2024
Common Stock issued for services
Preferred Stock redemption including cash premium
From March 31, 2024 to June 30, 2024
Common Stock issued for services
Preferred Stock redemption including cash premium
From December 31, 2023 to March 31, 2024
Preferred Stock redemption including cash premium
Common Stock issued for services
From December 31, 2022 to December 31, 2023
Stock-based compensation expense
Shares issued for vested RSU’s
Preferred Stock redemption including cash premium
From June 30, 2023 to September 30, 2023
Issuance of Series A Preferred Stock in private placement, net of discount and transaction costs $15,000,003
Preferred Stock redemption including cash premium
From March 31, 2023 to June 30, 2023
Shares issued for vested RSU’s
From December 31, 2022 to March 31, 2023
Shares issued for vested RSU's
From December 31, 2021 to December 31, 2022
Non-employee exercise of restricted stock units
Issuance of Common Stock for split
Petros Pharmaceuticals, Inc. announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 10 pre-split shares. The reverse stock split will become effective at 4:05 p.m. on Wednesday, November 30, 2022.
From June 30, 2022 to September 30, 2022
Non-employee exercise of restricted stock units
From December 31, 2020 to December 31, 2021
Conversion of Preferred Stock to Common Stock
Issuance of Common Stock
Proceeds from exercise of warrants
Stock-based compensation expense
Non-employee stock-based compensation
1.Common Stock offered 1,545,183 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering and the concurrent private placement as shown above is based on 18,448,134 shares outstanding as of December 22, 2021.
1.Common Stock offered by company 2,153,333 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering and the concurrent private placement as shown above is based on 14,297,284 shares outstanding as of November 29, 2021.
1.Common Stock offered by company 3,323,616 shares.
2.The number of shares of common stock that will be outstanding immediately after this offering as shown above is based on 9,826,599 shares outstanding as of October 13, 2021.
From March 31, 2021 to June 30, 2021
Issuance of Common Stock for Service
From December 31, 2020 To March 31, 2021
Conversion of Preferred Stock to Common Stock
Issuance of Common Stock for services
Stock-Based Compensation Expense
From December 31, 2019 to December 31, 2020
Net proceeds received from recapitalization for the Mergers